GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nippon Shinyaku Co Ltd (OTCPK:NPPNY) » Definitions » Capex-to-Revenue

Nippon Shinyaku Co (Nippon Shinyaku Co) Capex-to-Revenue : 0.01 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Nippon Shinyaku Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Nippon Shinyaku Co's Capital Expenditure for the three months ended in Dec. 2023 was $-3.81 Mil. Its Revenue for the three months ended in Dec. 2023 was $273.74 Mil.

Hence, Nippon Shinyaku Co's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.01.


Nippon Shinyaku Co Capex-to-Revenue Historical Data

The historical data trend for Nippon Shinyaku Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nippon Shinyaku Co Capex-to-Revenue Chart

Nippon Shinyaku Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.02 0.03 0.07 0.08

Nippon Shinyaku Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.18 0.06 0.05 0.01

Competitive Comparison of Nippon Shinyaku Co's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Shinyaku Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nippon Shinyaku Co's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nippon Shinyaku Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nippon Shinyaku Co's Capex-to-Revenue falls into.



Nippon Shinyaku Co Capex-to-Revenue Calculation

Nippon Shinyaku Co's Capex-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-87.742) / 1078.635
=0.08

Nippon Shinyaku Co's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-3.806) / 273.737
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nippon Shinyaku Co  (OTCPK:NPPNY) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Nippon Shinyaku Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nippon Shinyaku Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nippon Shinyaku Co (Nippon Shinyaku Co) Business Description

Traded in Other Exchanges
Address
14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto, JPN, 601-8550
Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company. Nippon's research and development activities include a focus on pharmaceuticals, nutraceuticals, safety and pharmacokinetics of drug seeds, genomic drug discovery, and nucleic acid drugs. The company also develops health food ingredients, preservatives, protein preparations, and spices. Nippon considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Nippon Shinyaku Co (Nippon Shinyaku Co) Headlines

No Headlines